Literature DB >> 10687968

Management of superficial transitional cell carcinoma in the intramural ureter: what to do?

J Palou1, J Salvador, F Millán, A Collado, F Algaba, J Vicente.   

Abstract

PURPOSE: We analyze the evolution of superficial transitional cell carcinoma in the intramural distal ureter treated with transurethral resection.
MATERIALS AND METHODS: A total of 19 patients underwent transurethral resection of the intramural distal ureter with a mean followup of 57 months. All cases were diagnosed as superficial transitional cell carcinoma and all but 2 had a history of bladder tumor. Upper urinary tract followup consisted of excretory urography every 6 months and ureterorenoscopy in cases with a doubtful diagnosis or positive cytology.
RESULTS: Pathological examination revealed stage Ta disease in 42%, T1 in 31.5% and Tx in 26.3% of intramural tumors. Upper urinary tract recurrence was noted in 8 patients (42.1%), including 5 (62.5%) with involvement of the distal ureter. Nontumoral stenosis of the distal ureter in 3 cases was treated endoscopically. An endoscopic procedure resolved 75% of recurrences. A high surgical risk patient who did not undergo open surgery died of recurrence.
CONCLUSIONS: Superficial transitional cell carcinoma of the intramural ureter is uncommon in the setting of multiple bladder tumors and recurrent bladder carcinoma. There was a 42.1% rate of ipsilateral recurrence and endoscopic treatment allowed us to preserve 89.5% of the involved renal units. Closer followup of the urinary tract must be performed since these tumors have a higher incidence of upper urinary tract recurrence.

Entities:  

Mesh:

Year:  2000        PMID: 10687968

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  2 in total

1.  A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis-assisted transurethral resection involving orally administered 5-aminolevulinic acid.

Authors:  Keitaro Watanabe; Suguru Shirotake; Yuta Umezawa; Takayuki Takahashi; Takeshi Yamanaka; Noriaki L Santo; Takashi Okabe; Gou Kaneko; Katsuhiro Sano; Masanori Yasuda; Kent Kanao; Masafumi Oyama; Koshiro Nishimoto
Journal:  IJU Case Rep       Date:  2019-09-13

2.  Ureteral orifice involvement by urothelial carcinoma: long term oncologic and functional outcomes.

Authors:  Muammer Altok; Ali F Sahin; Mehmet I Gokce; Gokhan R Ekin; Rauf Taner Divrik
Journal:  Int Braz J Urol       Date:  2017 Nov-Dec       Impact factor: 1.541

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.